Singapore, March 13 -- At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke with Dr David Chang, Chief Executive Officer of Taiwan Bio Manufacturing Corp (TBMC). With nearly three decades of leadership experience across Genentech, Roche, WuXi, and TBMC, Dr Chang offers a global perspective on how geopolitical shifts, regional manufacturing ecosystems, and smart automation are redefining the future of biomanufacturing. In this conversation, he discusses why Asia Pacific remains underutilised despite its growing capabilities, the urgent need for automation in advanced therapies such as cell and gene therapy, and how stronger regional collaboration could position APAC as a leadi...